Ready for your all-in-one single cell sequencing solution?
Contact us

Exploring Chemoresistance-Related Pathways in Neuroblastoma through Single Cell Transcriptomics
Watch now

Singleron Biotechnologies and Illumina are dedicated to providing cutting-edge technologies to empower and support researchers in addressing today’s major research questions.

Single cell sequencing is an increasingly popular approach for profiling gene expression of individual cells. It can be performed in a high throughput manner where the transcriptome of tens of thousands of cells can be analyzed in a single experiment. With this method, insights into cell-specific gene expression in thousands of cells can be obtained simultaneously. For example, single-cell sequencing has significantly advanced our understanding of neuroblastoma, a common pediatric cancer. 

In this joint webinar hear from Dr. Mario Capasso, on using single cell transcriptomics to unravel pathways related to chemoresistance in neuroblastoma. You will also learn about Singleron’s innovative single cell multi-omics solutions and Illumina’s latest sequencing technologies.

Discover more about the use of single cell sequencing in the field of neuroscience, here.

About the speakers

Mario Capasso, PhD; CEINGE, University of Naples Federico II

Mario Capasso is Professor of Medical Genetics at University of Naples Federico II where he and his research group investigate the genetic causes of neuroblastoma. He focuses on researching translational genomics in pediatric cancers.

Dr. Capasso has the expertise in bioinformatics and in vitro functional analysis of genomic data obtained by diverse methodological approaches such as SNP array, qPCR, Gene Expression array, Next Generation Sequencing. He has been able to identify the several neuroblastoma susceptibility genes (BARD1, NEFL, LIN28B).

Sophie Wehrkamp-Richter, PhD; Sr Product Marketing Manager, Illumina

Sophie is a Sr Product Marketing Manager at Illumina – where she manages collaborations for applications like methylation. Previously, she was working as an Applications Scientist to help Illumina customers troubleshoot their experiments. She holds a PhD in genetics from France. Dr. Wehrkamp-Richter has also done a few postdocs at Scripps Research and UCSD, focusing on DNA repair.

Wei Long, PhD; Product Manager, Singleron Biotechnologies

Wei Long has earned her MSc in Biotechnology at the Technical University of Braunschweig, Germany and her Ph.D. in Biotechnology from RWTH Aachen University, Germany. In 2021, she joined Singleron Biotechnologies as a Product Manager. As part of our team, she supports the development of new technologies and current portfolio.

Check out our latest webinars

Learn more